Company Analysis
Sign in

Aquestive Therapeutics, Inc. (AQST)

Nasdaq: AQST · Pharmaceutical Preparations · Warren, NJ · filing with the SEC since 2007
Full chart Alerts Compare
Grade4.0
◀ Past 4.1● Present 3.9▶ Future 4.1
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

66 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Aquestive Therapeutics, Inc.’s names, not what it holds today.

Patents granted
66
66 utility, 1976 to Dec 31, 2025
Granted in 2025
6
Against 2 in 2024 and 2 in 2023
Applications published
161
4 of them in 2025
Names they are printed under
4
a former name, its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals12
Medical technology3
Other special machines2
Handling1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
MonoSol Rx, LLC a former name
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in IN)
42 granted
93 published
AQUESTIVE THERAPEUTICS, INC. its own name
US, as the owner printed on each patent
24 granted
29 published
MonoSol Rx, LLC a former name
named as the applicant on its applications, in US
0 granted
23 published
Aquestive Therapeutics, Inc. its own name
named as the applicant on its applications, in US
0 granted
16 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 11, 202512,465,564Oral and nasal compositions and methods of treatmentPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Oct 7, 202512,433,850Enhanced delivery epinephrine and prodrug compositionsPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Sep 30, 202512,427,121Enhanced delivery epinephrine compositionsPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Sep 2, 202512,403,090Oral film compositions and dosage forms having precise active dissolution profilesPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
May 27, 202512,310,922System and method for making personalized individual unit doses containing pharmaceutical activesMedical technologyAQUESTIVE THERAPEUTICS, INC.
May 6, 202512,290,597Oral film compositions and dosage forms having precise active dissolution profilesPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Dec 24, 202412,171,723System and method for making personalized individual unit doses containing pharmaceutical activesMedical technologyAQUESTIVE THERAPEUTICS, INC.
Jul 2, 202412,023,309Enhanced delivery epinephrine compositionsPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Nov 7, 202311,806,311System and method for making personalized individual unit doses containing pharmaceutical activesMedical technologyAQUESTIVE THERAPEUTICS, INC.
Jan 3, 202311,541,002Oral film compositions and dosage forms having precise active dissolution profilesPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 6, 20252025/0339367ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILESPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Sep 11, 20252025/0281392TOPICAL DELIVERY OF EPINEPHRINE AND PRODRUG COMPOSITIONSPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Aug 14, 20252025/0255780SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVESMedical technologyAQUESTIVE THERAPEUTICS, INC.
Apr 3, 20252025/0108017ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONSPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
May 9, 20242024/0148673ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONSPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Feb 15, 20242024/0050317SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVESMedical technologyAQUESTIVE THERAPEUTICS, INC. · patent 12,171,723 granted from it
Jan 18, 20242024/0016734ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONSPharmaceuticalsAQUESTIVE THERAPEUTICS, INC.
Dec 28, 20232023/0414452SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVESMedical technologyAQUESTIVE THERAPEUTICS, INC. · patent 12,310,922 granted from it
May 18, 20232023/0149304ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILESPharmaceuticalsAQUESTIVE THERAPEUTICS, INC. · patent 12,403,090 granted from it
May 11, 20232023/0145752ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILESPharmaceuticalsAQUESTIVE THERAPEUTICS, INC. · patent 12,290,597 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 5 · Medical technology 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton AQST · research, not advice